IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Ricci, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.943
EU - Europa 4.127
AS - Asia 2.341
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 11
SA - Sud America 10
Totale 14.483
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.913
UA - Ucraina 1.465
CN - Cina 1.378
IT - Italia 617
DE - Germania 583
HK - Hong Kong 426
FI - Finlandia 379
PL - Polonia 355
SG - Singapore 261
IE - Irlanda 236
GB - Regno Unito 220
IN - India 204
FR - Francia 173
SE - Svezia 33
CA - Canada 29
TR - Turchia 28
MU - Mauritius 24
BE - Belgio 16
EU - Europa 16
IR - Iran 14
VN - Vietnam 12
AU - Australia 11
RU - Federazione Russa 9
ES - Italia 8
CZ - Repubblica Ceca 7
JP - Giappone 7
NL - Olanda 5
RO - Romania 5
CI - Costa d'Avorio 4
MK - Macedonia 4
UG - Uganda 4
EC - Ecuador 3
EE - Estonia 3
MY - Malesia 3
AR - Argentina 2
BD - Bangladesh 2
CL - Cile 2
ET - Etiopia 2
FK - Isole Falkland (Malvinas) 2
KW - Kuwait 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
LU - Lussemburgo 1
MD - Moldavia 1
MX - Messico 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 14.483
Salva come PNG Salva come JPEG
Città #
Fairfield 1.038
Jacksonville 1.012
Woodbridge 711
Ashburn 553
Houston 535
Chandler 451
Princeton 445
Ann Arbor 426
Hong Kong 426
Cambridge 419
Wilmington 412
Nanjing 372
Seattle 358
Warsaw 353
New York 250
Dearborn 248
Dublin 233
Helsinki 188
Beijing 158
Singapore 139
Nanchang 124
Des Moines 105
Milan 97
Shenyang 93
Brescia 92
Hebei 74
Jinan 72
Changsha 63
San Diego 56
Tianjin 55
Jiaxing 50
Shanghai 46
Kunming 41
Lancaster 37
Hangzhou 35
Verona 35
Boardman 30
Ningbo 29
San Francisco 28
Lanzhou 24
Pune 22
Los Angeles 21
Romola 21
San Mateo 21
Toronto 20
Zhengzhou 20
Springfield 18
Kocaeli 17
London 17
Augusta 16
Rome 16
Guangzhou 15
Leawood 15
Norwalk 15
Ardabil 13
Brussels 13
Changchun 13
Rozzano 13
Dong Ket 12
Hefei 12
Redwood City 12
Munich 11
Taiyuan 10
Taizhou 10
Fuzhou 9
Haikou 9
Monmouth Junction 9
Auburn Hills 8
Orange 8
Bologna 7
Casier 7
Indiana 7
Chiswick 6
Lambeth 6
Lappeenranta 6
Ottawa 6
Phoenix 6
Redmond 6
Stuttgart 6
Sydney 6
Tokyo 6
Gunzenhausen 5
Abidjan 4
Bergamo 4
Brno 4
Chicago 4
Melbourne 4
Mountain View 4
Mumbai 4
Parma 4
Ankara 3
Bangalore 3
Berlin 3
Buccinasco 3
Falls Church 3
Lonato 3
Misinto 3
Monopoli 3
Montichiari 3
Nuremberg 3
Totale 10.471
Salva come PNG Salva come JPEG
Nome #
Persistent intraepithelial lymphocytosis in celiac patients adhering to gluten-free diet is not abolished despite a gluten contamination elimination diet 241
Bio-physical characteristics of gastrointestinal mucosa of celiac patients: comparison with control subjects and effect of gluten free diet 204
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 198
A de novo monoallelic CTLA-4 deletion causing pediatric onset CVID with recurrent autoimmune cytopenias and severe enteropathy. 186
Increased risk of second malignancy in pancreatic intraductal papillary mucinous tumors: Review of the literature. 146
Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection:a randomised controlled trial 136
13C-urea breath test values and Helicobacter pylori eradication. 136
Localization of TNF alpha in ileocolonic biopsies of patients with inflammatory bowel disease 128
Ulcerative colitis and the aging-related development of colonic diverticula 128
Factors that contribute to hypertransaminasemia in patients with celiac disease or functional gastrointestinal syndromes 127
Helicobacter pylori infection: anything new should we know? 124
Impact of gluten-free diet on cardiovascular risk factors. A retrospective analysis in a large cohort of coeliac patients. 122
Five year time course of celiac disease serology during gluten free diet: results of a community based " CD-Watch" program. 120
Age, Helicobacter pylori and/or CagA antibodies as a pre-endoscopic screening policy 118
Absence of Helicobacter pylori in dental plaque assessed by stool test. 117
Adalimumab in active ulcerative colitis: A "real-life" observational study. 116
A rapid Immunochromatographic assay for Helicobacter pylori in stool before and after treatment 115
Randomised clinical study: Gluten challenge induces symptom recurrence in only a minority of patients who meet clinical criteria for non-coeliac gluten sensitivity 114
A rapid, low dose 13C Urea tablet for the detection of Helicobacter pylori infection before and after treatment 110
Best cut off values for 14C-urea breath tests for Helicobacter pylori detection 107
The clinical role of cytochrome P450 genotypes in Helicobacter pylori management 105
Diagnosis of Helicobacter pylori infection: which is the best test? Stool test 105
A comparison amongst three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic 105
Editorial: Noncoeliac gluten sensitivity - The controversy rages on. Authors' reply 103
High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease 102
High eradication rates for Helicobacter pylori with a new sequential treatment 101
Celiac disease with mild enteropathy is not mild disease 101
Letter: Gluten challenge in the era of noncoeliac gluten sensitivity - A change in clinical practice? Author's reply 101
Diagnosis and treatment of Helicobacter. A 2002 Updated review 99
Usefulness of serology in preendoscopic screening 99
Helicobacter pylori: storia e tassonomia 99
How valuable is the application on Consensus guidelines in the management of functional gastrointestinal disorders 97
Non invasive antigen based assay for assessing Helicobacter pylori eradication. A European multicenter study 96
Stool test for Helicobacter pylori 96
POST-INFECTIOUS IRRITABLE BOWEL SYNDROME FOLLOWING A WATER BORNE nOROVIRUS-eNTEROVIRUS GASTROENTERITIS OUTBREAK. 96
Helicobacter pylori: diseases, tests and treatment 95
Rifaximin suspension for the eradication of Helicobacter pylori 95
A serologic survey of Helicobacter pylori infection in 3281 patients endoscoped for upper gastrointestinal symptoms through Italia 94
Stool test for Helicobacter pylori 93
Effect of Proton Pump Inhibitors and Antacid Therapy on 13C-Urea Breath Tests and Stool Test for Helicobacter pylori Infection 92
Clinical expression of lymphocytic duodenosis in "mild enteropathy" celiac disease and in functional gastrointestinal syndromes 92
The multidisciplinary team for management of inflammatory bowel diseases 90
IgG Elisa antibodies and detection of Helicobacter pylori in elderly patients 90
Peptic ulcer and Helicobacter pylori. 90
C-Urea Breath Test Values and Helicobacter pylori Eradication 89
Search for atoxic cereals: a single blind, cross-over study on the safety of a single dose of Triticum monococcum, in patients with celiac disease. 89
Blood tests in management of Helicobacter pylori infection 88
Symptoms and Helicobacter pylori, any link 87
Five year time course of celiac disease serology during gluten free diet: Results of a community based " CD-Watch" program 87
Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection. 87
Disegno dello Studio e dati Preliminari del progetto SEELN (Steatosi Epatica non alcolica): Epidemiologia nutrizionale e Lifestyle Medicine 86
The Italian Registry of Therapeutic Apheresis: Granulocyte_Monocyte Apheresis in the Treatment of Inflammatory Bowel Disease. A Multicentric Study 85
Exhaled nitric oxide as a marker of lung involvement in Crohns disease. 85
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study 85
Newer agents for Helicobacter pylori eradication 82
Primary antibiotic resistance in Helicobacter pylori strains isolated in Northern and Central Italy 81
Helicobacter pylori status, endoscopic findings, and serology in HIV-1 -positive patients 81
Diagnosis of Helicobacter pylori infection: faecal antigen determination 80
Gastroesophageal reflux disease and Barrett's esophagus. 80
Regional differences of mucosal hydrophobicity in the gastrointestinal tract of healthy subjects 80
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 79
Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. 77
A new self-administered semi-quantitative food frequency questionnaire to estimate nutrient intake among Italian adults: Development design and validation process 77
Duodenal histological features in suspected non-celiac gluten sensitivity: new insights into a still undefined condition 77
A 10 days levofloxacin base triple therapy in patients who failed two eradication courses 76
Circulating ghrelin level is increased in coeliac disease as in functional dyspepsia and reverts to normal during gluten-free diet 75
Levofloxacin-based triple therapy for Helicobacter pylori retreatment: role of bacterial resistance 74
Incidence of post-infectious irritable bowel sydrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak 73
Potential celiac disease is not a mild disease: a single unit study in a color of 1140 patients 72
Accuracy of the stool antigen test in the pre- and post-eradication diagnosis of Helicobacter pylori infection, and in patients on omeprazole therapy 70
High Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study 69
Helicobacter pylori infection, anti-CagA antibodies and peptic ulcer in 1,626 patients: a case control study in Italy 69
Four years time course of celiac disease (CD) serology during gluten free diet (GFD) resluts of a community based program. 69
Tissue transglutaminases antibodies (T-TGA) level as predictor of villous atrophy among adult unselected patients twith sispected celiac disease (CD 69
Persistence of intraepithelial lymphocytosis in celiac patietns adherent to gluten free diet: is there a HLA gene dose effec or a role for Helicobacter pylori infection ? 69
Diagnosis of Helicobacter pylori infection 68
Laser-assisted ratio analyser (LARA) versus isotope ratio mass spectrometry (IRMS): a comparative study using two doses of 13C-urea and two test meals for pre- and post-treatment diagnosis of Helicobacter pylori infection 68
Are cardiovascular rik factors affected by gluten free diet in celiac patients? Results in a cohor of 765 patients. 67
Is severity of duodenal histopatology morrored by differences in clinical and laboratory presentation in celiac disease ? A single unit study in a cohort of 1140 patients. 67
Evaluation of systo-diastolic cardiac function and arterial stiffness in subjects with new diagnosis of coeliac disease without cardiovascular risk factors. 67
Accuracy of urea breath tests tablets after 10 minutes compared to standard 30 minutes to diagnose and monitoring Helicobacter pylori infection: a randomised controlled trial. 66
CARDIOVASCULAR RISK FACTORS ARE AFFECTED BY GLUTEN FREE DIET (GFD) IN CELIAC DISEASE (CD): RESULTS IN A COHORT OF 765 PATIENTS. 66
A second-line anti-Helicobacter pylori in theray in patients with previously failed treatment 65
Postinfectious functional intestinal disorders following a waterborn norovirus gastroenteritis our break 65
Authors' replay: Comment to "High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease" 65
Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: A pilot study 65
Extraintestinal manifestations in Crohn's disease: risk factors and influence of intestinal surgery. 64
Accurate diagnosis of Helicobacter pylori: stool tests 64
Celiac dsease at the time of dianosis: age-relted differences in clinical, serological and histopathological features 64
Is villous atrophy predictable by high tissue-transglutaminases antibodies (T-Tga) level in unselected adult patients evaluated for celiac disease (CD) ? 64
HLA gene dose effect and helicobacter pylori infection do not contribute to persistence od intraepithelial lymphocitosis frequently observed in celiac patients adherent to gluten free diet. 64
Increased serum gammaglutamyltranspeptidase activity: a surrogate marker of non alcoholic hepatic steatosis in chronic hepatitis C? . 64
Novel steps forward in the histopathology of non-celiac gluten sensitivity, authors’ reply 64
Amoxicillin-clavulanate-induced ischaemic colitis 64
Celiac disease in the elderly: clinical, serological and histological characteristics, and effect of gluten free diet 63
Celiac diseases at the time of diagosis in a cohort of 793 patietnts: age-related differences in clinical, serological and histopathogogical features. 63
HLA gene dose effect does not contribute to persistence of intraepithelial lymphocytosis frequently observed in celiac patientis adherent to gluten free diet. 63
five years time-course of transglutaminases (t-TG) antibodies and adherence to gluten free population based program. 63
A Prospective Clinical Trial on Safety and Efficacy of Antiviral Treatment of Chronic Hepatitis C in Active Illicit Drug Users 63
Fecal Calprotectin Thresholds to Predict Endoscopic Remission Using Advanced Optical Enhancement Techniques and Histological Remission in IBD Patients 63
Totale 9.195
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.857
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.857
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.932 0 0 0 406 166 504 366 415 180 480 151 264
2020/20212.717 64 298 91 297 105 302 69 375 449 235 363 69
2021/20221.643 71 299 24 117 30 77 62 129 93 188 184 369
2022/20231.465 258 32 45 100 111 433 5 132 207 12 68 62
2023/20241.763 86 38 81 161 97 381 71 50 445 33 27 293
2024/2025104 33 34 36 1 0 0 0 0 0 0 0 0
Totale 14.753